Seeking Alpha is often pretty thin on accuracy in their articles, but the interview with David Fischel, principal at DAFNA Capital Management (third largest institutional holder of STXS) at least gives good insight into their reasons for being bullish about STXS:
"Naomi: What would be your valuation of Stereotaxis?
David: Though they no longer directly compete, the most relevant comparable for Stereotaxis is Hansen Medical, Inc (HNSN) has about double the valuation of Stereotaxis but only a third of the revenue, a third the utilization, much lower margins, a much higher burn rate, and from my analysis, a much less exciting technology (has a system with only one mechanism of action similar to V-drive)."
yada yada yada, David ends up stating that STXS should be right around $20 today.
In the interview, David also makes valid comparisons between ISRG and STXS. Sounds good to me.
As ever, STILL Strong Long, STILL Strong Buy
Hold onto your shares, fellow longs! There are still lots of shares short out there (809K as of 08/15), and all of the shorties need to have their clocks cleaned!